741690-24-4Relevant articles and documents
DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A MORPHOLINE MOIETY
-
Paragraph 0234-0235, (2018/11/21)
The disclosure provides compounds of formula (I) or pharmaceutically acceptable salts thereof: The disclosure also provides processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them, and their use
DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS
-
Page/Page column 113; 118, (2016/05/19)
The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.
Triazole compounds and the use thereof as dopamine-D3 -ligands
-
, (2008/06/13)
Triazole compounds of the following formula: where Ar1, A, B and Ar2have the meanings given in the description, possess a high affinity for the dopamine D3receptor and can therefore be used for treating diseases which resp